Mohanalakshmi Babu

Date

: 17-06-2026 18:11

Age

: 60

MRD No.

: 20260000552

Gender

: Female

Ref. By

:

Specimen Date

: 17-06-2026 18:11
CDEC/LAB/26/18388

CDEC/LAB/26/18388

 

 

LAB REPORT

Investigation

Result

Unit

Normal Range

CBC

Total Count WBC

Blood/ Automated

7000

Cells/cmm

4000 - 11000

Hemoglobin

Blood/ Automated

9.2

g/dL

13.0 - 17.0

PCV

Blood/ Automated

27.6

%

40 - 50

Platelets

Blood/ Automated

314

thou cells/ ul

150 - 400

RBC Count

Blood/ Automated

3.06

million/ul

4.5 - 5.5

MCV

Blood/ Automated

85

fl

80 - 100

MCH

Blood/ Automated

27

pg

27 - 32

MCHC

Blood/ Automated

31

gm %

32 - 36

Neutrophils

Blood/ Automated

36

%

40 - 65

Lymphocytes

Blood/ Automated

59

%

30 - 50

Monocytes

Blood/ Automated

02

%

02 - 04

Eosinophils

Blood/ Automated

03

%

02 - 08

Basophils

Blood/ Automated

00

%

0 - 1

FREE T4,TSH

Free T4

CLIA

1.02

ng/dL

0.7 - 1.48

TSH

Method: CLIA

2.38

mIU/L

Adults : 0.35 - 5.1 Newborn - 4 Days : 1.0 - 38.9 Child - 14 Years : 1.0 - 9.1 Pregnancy Ranges::::, Ist Tri :0.1 - 2.5, IInd Tri :0.2 - 3.0, IIIrd Tri:0.3 - 3.0,

Lipid Profile

Total Cholesterol

Method: Enzymatic/CHOD/PAP / SERUM

160

mg/dl

Desirable : <200 Borderline high : 200 - 239 High : >239

TGL Triglyceride

Method: Glycerol-3-phosphate oxidase-PAP/ SERUM

135

mg/dL

Less than 200 : desirable 200 - 400 :Normal Risk More than 400 :High Risk

HDL High Density Lipoprotein

Method : Direct / SERUM

40

mg/dL

Low :< 40 High :>=60

LDL Low Density Lipoprotein

Method : Homogenous Enzymatic colorimetric / Serum

89

mg/dL

Optimal :<100 Near or above optimal : 100 - 129 Borderline high : 130 - 159 High : 160 - 189 Very high :>190

VLDL

Method : Calculation

27

mg/dl

15 - 35 mg/dl

TOTAL CHO/HDL RATIO

Method : Calculation

3.9

up to 5.0

Liver Function Test (LFT)

Total Bilirubin

0.26

mg/dL

Direct Bilirubin

Method: DSA / SERUM

0.13

mg/dl

Up to 0.4

Indirect Bilirubin

Method : Calculation / SERUM

0.13

SGPT (ALT)

Method: UV without pyridoxal phosphate / SERUM

14

IU/L

Adult Male :<45 Female:<34

SGOT (AST)

Method: UV without pyridoxal phosphate / SERUM

11

U/L

Adult Male :<35 Female:<31

Gamma Glutamyl transferase (GGT)

( Method: IFCC - Enzymatic Colorimetric / SERUM

16

U/L

Up to 55 U/L

Alkaline Phosphotase

Method : P-NPP/IFCC / SERUM

53

IU/L

Children : 180 - 341 (Age and gender dependent) 16 - 18 years 52 - 171 > 18 years 30 - 120

Total Protein

Method: Biuret / SERUM

6.63

g/dl

Adult : 6.4 - 8.3

Albumin (serum)

Method: Bromocresol Green/ SERUM

3.08

g/dL

Adult - 3.5 - 5.2

Globulin

Method : Calculation

3.5

g/dl

2.6 - 4.1

A\G RATIO

Method : Calculation

0.9

g/dl

1.5 - 3.3 g/dl

Other

Fasting Plasma Glucose (FPG)

Method :GOD- POD / PLASMA

287

mg/dL

Adult : 70 - 110 Children : 60 - 100

Post Prandial Glucose (2hPP)

Method :GOD- POD / PLASMA

362

mg/dL

80 - 140

Glycosylated Hemoglobin (HBA1C)

HPLC

12.3

%

Non Diabetic : Less than 5.6% Risk of Diabetes : 5.7% - 6.4 % Diabetes : More than 6.5% In known Diabetics :- Good Control : 6 - 7 % Fair Control : 7 - 8 % Poor Control : More than 8 %

BUN Blood Urea Nitrogen

Method : GLDH/Urease

28

mg/dL

6 - 24

Creatinine

Method : Enzymatic / SERUM

1.44

mg/dL

Cord : 0.6-1.2 Newborn 1-4 days : 0.3 - 1.0 Infant : 0.2 - 0.4 Child : 0.3 - 0.7 Adolescent: 0.5 - 1.0 Adult (18 - 60 years) Male : 0.62 - 1.1 Female :0.45 - 0.75

Microalbumin Creatinine Ratio

245

mcg/mg

1

Vitamin D (25 OH)

CLIA

7.2

ng/mL

Deficient : Less than 20 ng/ml Insufficiency : 20 - 30 ng/ml Sufficiency : 30 - 100 ng/ml Toxicity : >100 ng/ml

 

 

 

 

Notes
****** End of the Report ******

 

 

Biochemist / Lab Technician

DR MURUGANANTHAM,

 

Qualification : M.Sc., P.hd.,